All Members

Biogen Latvia

Industry: Healthcare/Pharmaceuticals
Website: http://www.biogen.com
Level: Corporate Contributing

Biogen Latvia is a US-based company and one of the world's largest biotechnology companies for the development and commercialization of therapies specializing in neurological disease research. Biogen was founded in 1978 and is one of the largest biotech companies, employing more than 7400 employees worldwide. The company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Biogen's turnover in 2019 was 14.4 billion US dollars.

< Back to Members

Feedback

AmCham is an invaluable resource that keeps us up to date with business issues and opportunities.

Mantautas Paskevicius, Country Manager of Strategic Staffing Solutions International

Being an AmCham member is a great opportunity of interacting with other members about business & market dynamics in Latvia and in all Baltic states. Looking forward to collectively supporting our future, particularly in the areas of talent sustainability and business progress.

Yesim Ozer, Market Director Mars Baltics